Regional Health Headlines
Today is April 19, 2024. All times in Eastern Daylight Time.
Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1
04/15/2024 - 12:00 PM
UroGen Announces FDA Acceptance of Investigational New Drug Application for UGN-103, a Next Generation Mitomycin-Based Formulation for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
04/15/2024 - 08:00 AM
NiKang Therapeutics Doses First Patient in a Phase 1/1b Study of NKT3447, an Oral, Selective Inhibitor of CDK2 Which Reduces Cyclin E Expression
04/15/2024 - 08:00 AM
LabVantage Celebrates Customer Success with Record Number of Software Deployments in FY 2024
04/15/2024 - 07:30 AM
Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results
04/15/2024 - 07:00 AM
Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024
04/15/2024 - 06:00 AM
Innate Pharma Announces Advancement of Sanofi-developed NK Cell Engager SAR443579 / IPH6101 Progressing to Phase 2 for Blood Cancer Patients
04/15/2024 - 01:00 AM
Exeltis USA, Inc. Launches Blues Away®, a First-of-its-Kind Postpartum Mood Support Dietary Supplement* for New Mothers Experiencing Postpartum Blues
04/12/2024 - 10:51 AM
1
2
« Previous
Get Business Wire News on Your Website
Terms of Use
|
© 2024 Business Wire
News
Industry News
News
Delaware Bio Observer
Press Releases
Featured Member
Delaware Bio Partners
Industry News
